Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Amortization of Deferred Charges (2017 - 2018)

Cogent Biosciences (COGT) has 1 years of Amortization of Deferred Charges data on record, last reported at $7000.0 in Q4 2018.

  • For Q4 2018, Amortization of Deferred Charges changed N/A year-over-year to $7000.0; the TTM value through Dec 2018 reached $23000.0, changed N/A, while the annual FY2025 figure was $601000.0, N/A changed from the prior year.
  • Amortization of Deferred Charges reached $7000.0 in Q4 2018 per COGT's latest filing, up from $5000.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $7000.0 in Q4 2018 and bottomed at $5000.0 in Q1 2018.